Form 8.3 SPIRE HEALTHCARE GROUP PLC

Summary by AI BETAClose X

Barclays disclosed on 05 Nov 2026 that as at 04 Nov 2026 it held 6,719,313 1p ordinary shares (1.67%) and cash‑settled derivative exposure of 6,305,660 shares (1.57%), giving total interests of 13,024,973 shares (3.23%) versus total short positions of 13,053,663 shares (3.24%)—a net short of 28,690 shares; it executed multiple purchases and sales on 04 Nov 2026 (largest listed purchase 443,996 at £2.4850) and numerous swaps/CFDs transacted around £2.484–£2.485, and confirmed no indemnity or related arrangements.

Disclaimer*

UK 100

Latest directors dealings